Faeth Therapeutics stock: PIKTOR data due by year-end
XRP Wallet Growth Outpaces Fund Demand as Election Rally Lifts Crypto
Bayer's Asundexian Green Light Arrives as Wall Street Rewrites Its Targets
Infineon's AI Ambitions Rest on Labs, Fabs and Fine Print, Not Announcements Alone
Almonty's Korean Listing Ambitions Run on a Different Clock Than Sangdong's Ramp-Up
Micron's Rough Week: Washington Politics, Chinese DRAM and a Cautious Kioxia All Weigh on the Stock
Otis Worldwide stock holds outlook after 6% Q3 sales growth
Jet.AI stock advances its shift toward AI infrastructure
H.B. Fuller stock clears 50-day average as analysts stay bullish
GlobalFoundries stock: Company posts record Q3 margin
Kubient stock: Former CEO sentenced over $1.3 million fraud
Jaguar Health stock: Crofelemer program targets 2027 MVID filing
Fulton Financial stock: Q3 profit reaches USD 114.1 million
International Bancshares stock heads into key third-quarter report
Great Southern Bancorp stock: Q3 hit by hedge charge
GE HealthCare stock raises 2026 outlook after Q3 beat
Gap stock enters November 19 earnings report at EUR 21.15
AMD's AI Boom Comes With a Price Tag Wall Street Is Still Calculating
Evonik Draws a Line at Talks With BASF While Analysts Reward Earnings, Not the Stock
Forestar stock faces lower profit and fiscal 2027 targets
Vulcan Energy's Funding Wins Don't Settle the Lithium Question
Equitable Holdings stock gains as Q3 operating EPS rises 19%
Emergent BioSolutions stock faces lower 2026 revenue outlook
Gates Industrial stock gets new belt product for industrial buyers
Invesque stock heads toward a go-private transaction with Magnetar
GitLab stock in focus after GitLab Orbit reaches general availability
Dogwood Therapeutics stock enters November with Phase 2b focus
H&R Block stock in focus ahead of fiscal 2027 results
Commerzbank's 5% Sector Lift Meets Its First Real Test: Q3 Numbers
Evotec's Nine-Month Beat Meets a Halved Target and a Trimmed JPMorgan Stake
BioNTech's Pipeline Faces Its Reckoning as Trial Data Cut Both Ways
BYD's Autonomous Bus Debut Arrives as Investors Wait on Earnings Proof
Galectin Therapeutics stock: AASLD presentations spotlight belapectin
High Tide stock outlines Canada and Germany growth path